Lista de obras -

13.4 CANNABINOID RECEPTOR GENE POLYMORPHISMS AND COGNITIVE PERFORMANCE IN PATIENTS WITH SCHIZOPHRENIA.

artículo científico publicado en 2018

175.4 The Relationship of Aging and Inflammatory Biomarkers to Gray Matter Volume and Episodic Memory Performance in Schizophrenia: Evidence of Pathological Accelerated Aging.

artículo científico publicado en 2017

Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: Participation of antioxidant, nitrergic and neurotrophic mechanisms

artículo científico publicado en 2015

Analyzing leukocyte telomere length in bipolar disorder: Authors' reply

artículo científico publicado en 2017

Anatomical faces of neuroprogression in bipolar disorder

Anxiolytic properties of N-acetylcysteine in mice

artículo científico publicado en 2016

Association of biomarkers and depressive symptoms in schizophrenia

artículo científico publicado en 2011

Association of the gene encoding neurogranin with schizophrenia in males

artículo científico publicado en 2008

BDNF: a biomarker for social vulnerability in individuals diagnosed with gender dysphoria.

artículo científico publicado en 2013

Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis

artículo científico publicado en 2011

Brain-derived neurotrophic factor: a modifiable common mediator in both the pathophysiology of psychiatric illness and in successful pharmacological treatments

scholarly article by Felice N. Jacka et al published August 2008 in Acta Neuropsychiatrica

Brazilian Consensus on second-generation antipsychotics and metabolic disorders

artículo científico publicado en 2008

Changes in verbal learning of patients with schizophrenia: Results from a randomized, double-blind, placebo-controlled trial of amantadine adjunctive to antipsychotics

artículo científico publicado en 2015

Clinical Staging in Bipolar Disorder

article published in 2014

Decreased serum neurotrophin 3 in chronically medicated schizophrenic males

artículo científico publicado en 2008

Early intervention in bipolar disorders: clinical, biochemical and neuroimaging imperatives

artículo científico publicado en 2008

Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia

artículo científico publicado en 2012

Effects of omega-3 supplementation on interleukin and neurotrophin levels in an animal model of schizophrenia

artículo científico publicado en 2015

Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia

artículo científico publicado en 2008

Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine

artículo científico publicado en 2006

Elevated serum thiobarbituric acid reactive substances in clinically symptomatic schizophrenic males

artículo científico publicado en 2008

F174. OBESITY AND BRAIN INTEGRITY IN SCHIZOPHRENIA AND BIPOLAR DISORDER: DIVERGENT PATTERNS OF WHITE MATTER MICROSTRUCTURE DAMAGE IN A TRANSDIAGNOSTIC APPROACH.

artículo científico publicado en 2018

Family-based and case-control studies reveal no association of lipocalin-type prostaglandin D2 synthase with schizophrenia

artículo científico publicado en 2007

Functioning in early and late stages of schizophrenia

artículo científico publicado en 2014

G-protein gene 825C>T polymorphism is associated with response to clozapine in Brazilian schizophrenics

artículo científico publicado en 2008

Hippocampus size does not correlate with body mass index in bipolar disorder

artículo científico publicado en 2016

Imaging Social and Environmental Factors as Modulators of Brain Dysfunction: Time to Focus on Developing Non-Western Societies

Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine

artículo científico publicado en 2009

Influence of serotonin transporter gene polymorphisms on clozapine response in Brazilian schizophrenics

artículo científico publicado en 2010

Lack of association between serum brain-derived neurotrophic factor levels and improvement of schizophrenia symptoms in a double-blind, randomized, placebo-controlled trial of memantine as adjunctive therapy to clozapine

artículo científico publicado en 2010

Long-term treatment with clozapine and verbal memory performance in schizophrenia.

artículo científico publicado en 2018

Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial

artículo científico publicado en 2012

Memantine as an adjunctive therapy for schizophrenia negative symptoms

artículo científico publicado en 2005

Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial

artículo científico publicado en 2009

Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects

artículo científico publicado en 2013

Molecular diversity at the CYP2D6 locus in healthy and schizophrenic southern Brazilians

artículo científico publicado en 2009

Myocardial disease in a patient treated with clozapine

artículo científico publicado en 2005

NR4A2 and schizophrenia: lack of association in a Portuguese/Brazilian study

artículo científico publicado en 2004

Nail-biting stuff? The effect of N-acetyl cysteine on nail-biting

artículo científico publicado en 2009

Naturalistic pharmacogenetic study of treatment resistance to typical neuroleptics in European-Brazilian schizophrenics

artículo científico publicado en 2008

Neurobiological underpinnings of bipolar disorder focusing on findings of diffusion tensor imaging: a systematic review

artículo científico publicado en 2016

O impacto dos agentes antipsicóticos na densidade mineral óssea de pacientes esquizofrênicos

Obesity is associated with previous suicide attempts in bipolar disorder

artículo científico publicado en 2010

Peripheral biomarkers and illness activity in bipolar disorder

artículo científico publicado en 2010

Pharmacological treatment and staging in bipolar disorder: evidence from clinical practice

artículo científico publicado en 2015

Physical Functional Capacity and C-Reactive Protein in Schizophrenia

artículo científico publicado en 2016

Pinocembrin Provides Mitochondrial Protection by the Activation of the Erk1/2-Nrf2 Signaling Pathway in SH-SY5Y Neuroblastoma Cells Exposed to Paraquat

artículo científico publicado en 2016

Psychiatric and neurological symptoms in patients with Niemann-Pick disease type C (NP-C): Findings from the International NPC Registry

artículo científico publicado en 2017

Revisiting the Role of Eotaxin-1/CCL11 in Psychiatric Disorders.

artículo científico publicado en 2018

Right hippocampus size is negatively correlated with leptin serum levels in bipolar disorder

artículo científico publicado en 2015

Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients

artículo científico publicado en 2009

Serum brain-derived neurotrophic factor and cortical thickness are differently related in patients with schizophrenia and controls

artículo científico publicado en 2015

Serum brain-derived neurotrophic factor in bipolar and unipolar depression: a potential adjunctive tool for differential diagnosis

artículo científico publicado en 2009

Serum concentrations of brain-derived neurotrophic factor in patients diagnosed with gender dysphoria undergoing sex reassignment surgery

artículo científico publicado en 2017

Serum concentrations of brain-derived neurotrophic factor in patients with gender identity disorder

artículo científico publicado en 2013

Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance

Serum levels of brain-derived neurotrophic factor and thiobarbituric acid reactive substances in chronically medicated schizophrenic patients: a positive correlation

artículo científico publicado en 2008

Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder

artículo científico publicado en 2007

Serum levels of brain-derived neurotrophic factor in schizophrenia on a hypocaloric diet

artículo científico publicado en 2008

Shortened telomere length in bipolar disorder: a comparison of the early and late stages of disease

artículo científico publicado en 2016

Staging and neuroprogression in bipolar disorder: a systematic review of the literature

artículo científico

Symptom dimensional approach and BDNF in unmedicated obsessive-compulsive patients: an exploratory study

artículo científico publicado en 2011

T68. DIFFERENT INFLUENCES OF INTELLECTUAL FUNCTIONING AND COGNITIVE PERFORMANCE TO FUNCTIONAL OUTCOMES IN SCHIZOPHRENIA AND HEALTHY CONTROLS.

artículo científico publicado en 2018

Telomere Length and CCL11 Levels are Associated With Gray Matter Volume and Episodic Memory Performance in Schizophrenia: Evidence of Pathological Accelerated Aging

artículo científico publicado en 2017

Telomere length in subjects with schizophrenia, their unaffected siblings and healthy controls: Evidence of accelerated aging.

artículo científico publicado en 2016

The Relationship of Intellectual Functioning and Cognitive Performance to Brain Structure in Schizophrenia

artículo científico publicado en 2016

The association of child abuse and neglect with adult disability in schizophrenia and the prominent role of physical neglect

artículo científico publicado en 2009

The concept of staging in bipolar disorder: the role of BDNF and TNF-alpha as biomarkers

The effect of sunlight exposure on interleukin-6 levels in depressive and non-depressive subjects

artículo científico publicado en 2013

The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial

artículo científico publicado en 2011

Transthyretin: no association between serum levels or gene variants and schizophrenia

artículo científico publicado en 2006

Treatment delay is associated with more episodes and more severe illness staging progression in patients with bipolar disorder

artículo científico publicado en 2015

Validity of the Portuguese version of the Bipolar Depression Rating Scale

article

Verbal episodic memory along the course of schizophrenia and bipolar disorder: a new perspective

artículo científico publicado en 2014

Verbal memory impairment in healthy siblings of patients with schizophrenia

artículo científico publicado en 2013

Lista de obras de

13.4 CANNABINOID RECEPTOR GENE POLYMORPHISMS AND COGNITIVE PERFORMANCE IN PATIENTS WITH SCHIZOPHRENIA.

175.4 The Relationship of Aging and Inflammatory Biomarkers to Gray Matter Volume and Episodic Memory Performance in Schizophrenia: Evidence of Pathological Accelerated Aging.

Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: Participation of antioxidant, nitrergic and neurotrophic mechanisms

Analyzing leukocyte telomere length in bipolar disorder: Authors' reply

Anatomical faces of neuroprogression in bipolar disorder

Anxiolytic properties of N-acetylcysteine in mice

Association of biomarkers and depressive symptoms in schizophrenia

Association of the gene encoding neurogranin with schizophrenia in males

BDNF: a biomarker for social vulnerability in individuals diagnosed with gender dysphoria.

Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis

Brain-derived neurotrophic factor: a modifiable common mediator in both the pathophysiology of psychiatric illness and in successful pharmacological treatments

Brazilian Consensus on second-generation antipsychotics and metabolic disorders

Changes in verbal learning of patients with schizophrenia: Results from a randomized, double-blind, placebo-controlled trial of amantadine adjunctive to antipsychotics

Clinical Staging in Bipolar Disorder

Decreased serum neurotrophin 3 in chronically medicated schizophrenic males

Early intervention in bipolar disorders: clinical, biochemical and neuroimaging imperatives

Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia

Effects of omega-3 supplementation on interleukin and neurotrophin levels in an animal model of schizophrenia

Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia

Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine

Elevated serum thiobarbituric acid reactive substances in clinically symptomatic schizophrenic males

F174. OBESITY AND BRAIN INTEGRITY IN SCHIZOPHRENIA AND BIPOLAR DISORDER: DIVERGENT PATTERNS OF WHITE MATTER MICROSTRUCTURE DAMAGE IN A TRANSDIAGNOSTIC APPROACH.

Family-based and case-control studies reveal no association of lipocalin-type prostaglandin D2 synthase with schizophrenia

Functioning in early and late stages of schizophrenia

G-protein gene 825C>T polymorphism is associated with response to clozapine in Brazilian schizophrenics

Hippocampus size does not correlate with body mass index in bipolar disorder

Imaging Social and Environmental Factors as Modulators of Brain Dysfunction: Time to Focus on Developing Non-Western Societies

Imaging Social and Environmental Factors as Modulators of Brain Dysfunction: Time to Focus on Developing Non-Western Societies

Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine

Influence of serotonin transporter gene polymorphisms on clozapine response in Brazilian schizophrenics

Lack of association between serum brain-derived neurotrophic factor levels and improvement of schizophrenia symptoms in a double-blind, randomized, placebo-controlled trial of memantine as adjunctive therapy to clozapine

Long-term treatment with clozapine and verbal memory performance in schizophrenia.

Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial

Memantine as an adjunctive therapy for schizophrenia negative symptoms

Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial

Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects

Molecular diversity at the CYP2D6 locus in healthy and schizophrenic southern Brazilians

Myocardial disease in a patient treated with clozapine

NR4A2 and schizophrenia: lack of association in a Portuguese/Brazilian study

Nail-biting stuff? The effect of N-acetyl cysteine on nail-biting

Naturalistic pharmacogenetic study of treatment resistance to typical neuroleptics in European-Brazilian schizophrenics

Neurobiological underpinnings of bipolar disorder focusing on findings of diffusion tensor imaging: a systematic review

O impacto dos agentes antipsicóticos na densidade mineral óssea de pacientes esquizofrênicos

Obesity is associated with previous suicide attempts in bipolar disorder

Peripheral biomarkers and illness activity in bipolar disorder

Pharmacological treatment and staging in bipolar disorder: evidence from clinical practice

Physical Functional Capacity and C-Reactive Protein in Schizophrenia

Pinocembrin Provides Mitochondrial Protection by the Activation of the Erk1/2-Nrf2 Signaling Pathway in SH-SY5Y Neuroblastoma Cells Exposed to Paraquat

Psychiatric and neurological symptoms in patients with Niemann-Pick disease type C (NP-C): Findings from the International NPC Registry

Revisiting the Role of Eotaxin-1/CCL11 in Psychiatric Disorders.

Right hippocampus size is negatively correlated with leptin serum levels in bipolar disorder

Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients

Serum brain-derived neurotrophic factor and cortical thickness are differently related in patients with schizophrenia and controls

Serum brain-derived neurotrophic factor in bipolar and unipolar depression: a potential adjunctive tool for differential diagnosis

Serum concentrations of brain-derived neurotrophic factor in patients diagnosed with gender dysphoria undergoing sex reassignment surgery

Serum concentrations of brain-derived neurotrophic factor in patients with gender identity disorder

Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance

Serum levels of brain-derived neurotrophic factor and thiobarbituric acid reactive substances in chronically medicated schizophrenic patients: a positive correlation

Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder

Serum levels of brain-derived neurotrophic factor in schizophrenia on a hypocaloric diet

Shortened telomere length in bipolar disorder: a comparison of the early and late stages of disease

Staging and neuroprogression in bipolar disorder: a systematic review of the literature

Symptom dimensional approach and BDNF in unmedicated obsessive-compulsive patients: an exploratory study

T68. DIFFERENT INFLUENCES OF INTELLECTUAL FUNCTIONING AND COGNITIVE PERFORMANCE TO FUNCTIONAL OUTCOMES IN SCHIZOPHRENIA AND HEALTHY CONTROLS.

Telomere Length and CCL11 Levels are Associated With Gray Matter Volume and Episodic Memory Performance in Schizophrenia: Evidence of Pathological Accelerated Aging

Telomere length in subjects with schizophrenia, their unaffected siblings and healthy controls: Evidence of accelerated aging.

The Relationship of Intellectual Functioning and Cognitive Performance to Brain Structure in Schizophrenia

The association of child abuse and neglect with adult disability in schizophrenia and the prominent role of physical neglect

The concept of staging in bipolar disorder: the role of BDNF and TNF-alpha as biomarkers

The effect of sunlight exposure on interleukin-6 levels in depressive and non-depressive subjects

The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial

Transthyretin: no association between serum levels or gene variants and schizophrenia

Treatment delay is associated with more episodes and more severe illness staging progression in patients with bipolar disorder

Validity of the Portuguese version of the Bipolar Depression Rating Scale

Verbal episodic memory along the course of schizophrenia and bipolar disorder: a new perspective

Verbal memory impairment in healthy siblings of patients with schizophrenia